Thursday, May 8, 2025

Latest

FSD Pharma to Conduct Raise Near All Time Low

FSD Pharma (CSE: HUGE) continued its relentlessly investor-friendly actions last night, after posting financials late in the evening, followed by a twelve AM press release to announce that it would be conducting a raise a penny off its all time low. In total, the company generated just $18,501 in revenue during the quarter – rental income – while managing to blow through over $990,000 in advertising alone.

FSD Pharma Logo
FSD Pharma Logo

Total expenses for the quarter consisted of $9.80 million, of which $5.38 million consisted of share based payments. General and administrative expenses were next on the list, at $1.51 million, followed by the aforementioned advertising at $0.99 million. Salaries and wages were the fourth largest expense, at $0.91 million. In total, FSD Pharma lost $14.24 million over the three month period, or $0.01 per share.

Total cash consumed over the quarter amounted to $7.26 million. As of June 30, 2019, FSD had $9.84 million remaining in the till. Which leads us to the next topic of discussion – the raise announced this morning.

FSD Pharma is currently in the process of raising US$5 million, to be used towards the operations of recently acquired Prismic Pharma. With units priced at $0.10 each, approximately 66.33 million shares will be issued in connection with the offering. The kicker, is that despite being a penny off the 52 week low price for the equity, no warrants are being offered with the financing.

As a result, the firm has attempted to round up investor support by indicating that C$1.3 million has already been sourced for funding, of which over C$1.1 million is from members of management. FSD expects the financing to close by the end of September.

FSD Pharma is currently trading at $0.10 on the Canadian Securities Exchange.


Information for this briefing was found via Sedar and FSD Pharma. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Giant Mining Encounters Native Copper As Hole MHB-34 Hits 563 Metres Depth

Related News

Market Movers: FSD Pharma Climbs 46% in Intraday Trading

FSD Pharma (CSE: HUGE) has experienced a massive run up this week on the back...

Tuesday, January 7, 2020, 03:36:46 PM

FSD Pharma To Forfeit Cannabis License, Liquidate FV Pharma To Focus On Coronavirus

FSD Pharma (CSE: HUGE) (NASDAQ: HUGE) this morning announced that it is going all in...

Thursday, July 30, 2020, 08:25:40 AM

FSD Pharma Commences Nasdaq Trading January 9, 2020

Much to the disbelief of many, it has finally happened. FSD Pharma (CSE: HUGE) (NASDAQ:...

Monday, January 6, 2020, 09:02:11 AM

Auxly Cannabis Clarifies FSD Pharma Joint Venture Termination

Auxly Cannabis (TSXV: XLY, OTCMKTS: CBWTF) clarified yesterday the termination of its joint venture with...

Friday, February 8, 2019, 02:00:35 PM

Is FSD Pharma Really so Huge?

FSD Pharma Inc (CSE: HUGE, OTCMKTS: FSDDF) is for all intents and purposes focused solely...

Thursday, December 13, 2018, 02:00:50 PM